David Happel

David Happel

Verkställande Direktör på SAGIMET BIOSCIENCES INC.

Förmögenhet: 2 M $ per 2026-05-31

64 år
Health Technology
Commercial Services
Consumer Services

Profil

David A. Happel is President, Chief Executive Officer & Director at Sagimet Biosciences, Inc. since 2022.
Former roles include Chief Executive Officer at Chrono Therapeutics, Inc. from 2018 to 2020; President & Chief Executive Officer at Cognoa, Inc. from 2020 to 2022; Director-Global Marketing at Warner-Lambert Co. in 2000; Senior Director-Pulmonary Business Unit at InterMune, Inc. in 2002; Director at Boomer Esiason Foundation; Vice President-Pulmonology at Chiron Corp.
in 2006; Head-Sales at Pfizer Inc.; Vice President-Global Sales & Marketing at Dynavax Technologies Corp.; Chief Commercial Officer & EVP at Aerovance, Inc.; Executive Vice President-Orphan Business Unit at Horizon Therapeutics Ltd. (Ireland) from 2016 to 2018; Principal at Parke, Davis & Co. LLC; and Chief Commercial Officer at Horizon Pharmaceutical LLC from 2014 to 2016.
Education includes an MBA from Indiana State University in 1991 and an undergraduate degree from Indiana University in 1984.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-05-28 278 166 ( 0,45 % ) 2 M $ 2026-05-31

Aktiva positioner av David Happel

FöretagPositionStart
SAGIMET BIOSCIENCES INC. Verkställande Direktör 2022-10-24

Tidigare kända positioner av David Happel

FöretagPositionSlut
Verkställande Direktör 2022-11-14
Verkställande Direktör 2020-03-01
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Företagsledare/Principal 2018-02-01
RAPTOR PHARMACEUTICAL CORP Företagsledare/Principal 2016-10-01
Företagsledare/Principal 2006-01-01
Se detaljerna i David Happels erfarenhet

David Happels utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

82

Första gradens relationer

15

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Services

  1. Börsen
  2. Insiders
  3. David Happel